Filing Flows › Agilent Technologies (A) › How it makes money
How Agilent Technologies (A) makes money
Agilent Technologies (A) made $1.9B of revenue in the third quarter fiscal 2026 (Q3 FY26), +8% from a year earlier. Agilent CrossLab brought in $786M (42%); Life Sciences and Diagnostics Markets brought in $746M (40%); Applied Markets brought in $346M (18%). Of every dollar of revenue, 24¢ was left as operating profit, 19¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 FY26
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Agilent CrossLab | $786M | 41.9% | +4% | +6% |
| Life Sciences and Diagnostics Markets | $746M | 39.7% | +2% | +11% |
| Applied Markets | $346M | 18.4% | +0.6% | +7% |
Where each dollar of revenue goes
| Line | Q3 FY26 | % of revenue |
|---|---|---|
| Revenue | $1.9B | 100.0% |
| Operating profit | $444M | 23.6% |
| Income tax | $82.0M | 4.4% |
| Net earnings | $362M | 19.3% |
| Operating cash flow | $519M | 27.6% |
| Free cash flow | $439M | 23.4% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 FY26 | $1.9B | +8% |
| Q2 FY26 | $1.8B | +10% |
| Q1 FY26 | $1.8B | +7% |
| Q4 FY25 | $1.9B | +9% |
| Q3 FY25 | $1.7B | +10% |
| Q2 FY25 | $1.7B | +6% |
| Q4 FY24 | $1.7B | +0.8% |
From Agilent Technologies' 10-Q filed Sep 1, 2026 (on EDGAR).
Questions
How does Agilent Technologies make money?
Agilent Technologies (A) made $1.9B of revenue in the third quarter fiscal 2026 (Q3 FY26), +8% from a year earlier. Agilent CrossLab brought in $786M (42%); Life Sciences and Diagnostics Markets brought in $746M (40%); Applied Markets brought in $346M (18%). Of every dollar of revenue, 24¢ was left as operating profit, 19¢ was left as net earnings.
What is Agilent Technologies' biggest business?
Agilent CrossLab: $786M in the third quarter fiscal 2026, 42% of revenue, +6% from a year earlier.
What is Agilent Technologies' profit margin?
Net earnings were $362M, 19.3% of revenue, in the third quarter fiscal 2026; the operating margin was 23.6%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.